United States · Funded startup
3 rounds we have observed, with the 17 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Raised this month
Funding summaryUpdated 26 Oct 2026
$189Mraised across 3 rounds since 2019, from 3 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $15M sold, first sale Jun 2021
From the SEC filings it signed: 5 on the team.
On the board, as filediAshish KhannaEdgar EnglemanJames HealyKathleen LaPorteMahendra ShahPeter MoldtRichard Miller
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Missing a round, or an investor who was in one? Tell us.
Bolt Biotherapeutics's investors include Pivotal bioVenture Partners, Andreessen Horowitz, RA Capital Management, Novo Holdings and Vivo Capital, and 12 more on record.
Bolt Biotherapeutics has raised $189M across 3 rounds since 2019.
Bolt Biotherapeutics's most recent round was an Undisclosed round of $120M in Oct 2026.
Its most recent round, $120M in Oct 2026, is also its largest on record.
Bolt Biotherapeutics's first round on record, in Feb 2019, was backed by Pivotal bioVenture Partners.
Bolt Biotherapeutics's latest named round is an Undisclosed round, in Oct 2026.
Bolt Biotherapeutics is based in the United States.
Pivotal bioVenture Partners led the Series B in 2019.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
